| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/10/2011 | CA2417806C New immunoeffector compounds |
| 05/10/2011 | CA2416293C Somatostatin analogues |
| 05/10/2011 | CA2344590C Treatment of inflammatory disease |
| 05/05/2011 | WO2011053821A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | WO2011053090A2 Novel 2, 4-pyrimidine derivatives and use thereof |
| 05/05/2011 | WO2011052950A2 Pharmaceutical composition comprising indole compound |
| 05/05/2011 | WO2011051452A1 N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| 05/05/2011 | WO2011051375A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them |
| 05/05/2011 | WO2011051270A1 Method of treatment |
| 05/05/2011 | WO2011051269A1 Method of treatment |
| 05/05/2011 | WO2011051264A2 Method of treatment |
| 05/05/2011 | WO2011050590A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof |
| 05/05/2011 | WO2011039511A9 Agents, uses and methods |
| 05/05/2011 | WO2010151737A3 Heterocyclic compounds and their uses as inhibitors of pi3 k activity |
| 05/05/2011 | WO2010146568A3 Bifidobacteria for treating diabetes and related conditions |
| 05/05/2011 | US20110105748 Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 05/05/2011 | US20110105624 Endipalene formulations in the treatment of psoriasis |
| 05/05/2011 | US20110105621 Method of reducing brain cell damage, inflammation or death |
| 05/05/2011 | US20110105620 Organic compounds |
| 05/05/2011 | US20110105613 Moisture resistant container systems for rapidly bioavailable dosage forms |
| 05/05/2011 | US20110105611 Use of maslinic acid for the treatment of pathologies and their symptoms through the inhibition of cox-2 |
| 05/05/2011 | US20110105607 Lipophilic diesters of chelating agent for inhibition of enzyme activity |
| 05/05/2011 | US20110105606 Compositions and methods affecting the signaling pathways of LRP receptors |
| 05/05/2011 | US20110105567 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity |
| 05/05/2011 | US20110105563 Il-8 receptor antagonists |
| 05/05/2011 | US20110105559 Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy |
| 05/05/2011 | US20110105552 Beloxepin and analogs for the treatment of pain |
| 05/05/2011 | US20110105551 Analgesics for nasal administration |
| 05/05/2011 | US20110105549 Branched 3- and 6-substituted quinolines as cgrp receptors antagonists |
| 05/05/2011 | US20110105548 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 05/05/2011 | US20110105546 Spirotropane compounds |
| 05/05/2011 | US20110105545 GPBP inhibition using Q2 peptidomimetics |
| 05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105538 Drug response markers |
| 05/05/2011 | US20110105535 Inhibitors of phosphatidylinositol 3-kinase |
| 05/05/2011 | US20110105527 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | US20110105509 Indole based receptor crth2 antagonists |
| 05/05/2011 | US20110105508 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/05/2011 | US20110105495 CYCLOPENTATHIOPHENE MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 05/05/2011 | US20110105490 2,3-dihydro-1h-isoindol-1-imine derivatives useful as thrombin par-1 receptor antagonist |
| 05/05/2011 | US20110105488 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
| 05/05/2011 | US20110105487 Filamin a binding anti-inflammatory and analgesic |
| 05/05/2011 | US20110105484 Filamin a-binding anti-inflammatory analgesic |
| 05/05/2011 | US20110105482 Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders |
| 05/05/2011 | US20110105481 Filamin a binding anti-inflammatory and analgesic |
| 05/05/2011 | US20110105480 Pharmaceutical transdermal compositions and method for treating inflammation in cattle |
| 05/05/2011 | US20110105479 Inhibitors of Bruton's Tyrosine Kinase |
| 05/05/2011 | US20110105478 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105464 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 05/05/2011 | US20110105462 Modulators of dopamine neurotransmission |
| 05/05/2011 | US20110105461 Modulators of dopamine neurotransmission |
| 05/05/2011 | US20110105459 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105457 Heterocyclic compound having inhibitory activity on pi3k |
| 05/05/2011 | US20110105455 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105443 Salts of memantine and cox-inhibitors and their crystal form in the treatment of pain |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105434 2-amino purine derivatives and their use as anti-herpetic agents |
| 05/05/2011 | US20110105430 Pyrrolo [2,3-c] pyridine derivatives as p38 kinease inhibiting agents |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105426 Compositions and methods for treating corneal inflammation |
| 05/05/2011 | US20110105419 Pharmacological adjuvants based on coordination compounds of d-metals |
| 05/05/2011 | US20110105414 Cyclic, cystein-free protein |
| 05/05/2011 | US20110105405 Method for alleviating pain using protein associated with myc and related compounds, and assays for identifying such compounds |
| 05/05/2011 | US20110105399 Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using mfg-e8 |
| 05/05/2011 | US20110105395 Methods for treating a neurological disorder by peripheral administration of a trophic factor |
| 05/05/2011 | US20110104313 Compositions for the treatment of vaginal infections with chronic inflammation |
| 05/05/2011 | US20110104308 Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide |
| 05/05/2011 | US20110104296 Endorphin Therapy Compositions and Methods |
| 05/05/2011 | US20110104295 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
| 05/05/2011 | US20110104281 Method for treating pain using a substituted 2-aminotetralin compound |
| 05/05/2011 | US20110104272 Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine |
| 05/05/2011 | US20110104269 Compositions for the oral delivery of corticosteroids |
| 05/05/2011 | US20110104263 Claudin-4 binding peptides, compositions and methods of use |
| 05/05/2011 | US20110104258 Technique for drug and gene delivery to the cell cytosol |
| 05/05/2011 | US20110104253 Agent for intra-articular injection |
| 05/05/2011 | US20110104245 Pressure-sensitive adhesives based on ethylene-vinyl acetate copolymers and adhesive resins, for medical application purposes |
| 05/05/2011 | US20110104236 Therapeutic compositions for treatment of ocular inflammatory disorders |
| 05/05/2011 | US20110104219 Denture care composition |
| 05/05/2011 | US20110104217 Bioactive Peptides and Method of Using Same |
| 05/05/2011 | US20110104215 Transdermally absorbable preparation |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104185 Antibody fragment-polymer conjugates and uses of same |
| 05/05/2011 | US20110104181 Modulation of synaptogenesis |
| 05/05/2011 | US20110104179 Protease inhibitory peptides |
| 05/05/2011 | US20110104174 Antibodies to receptor for advanced glycation end products (rage) and uses thereof |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104166 Methods and Compositions for Treating Polyps |
| 05/05/2011 | US20110104164 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 05/05/2011 | US20110104156 Methods and materials for treating autoimmune and/or complement mediated diseases and conditions |
| 05/05/2011 | US20110104145 Method for the treatment or prophylaxis of chronic inflammatory diseases |
| 05/05/2011 | US20110104116 Hsa-free formulations of interferon-beta |
| 05/05/2011 | US20110104103 Method of conjugating therapeutic compounds to cell targeting devices via metal complexes |
| 05/05/2011 | US20110104083 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye |